Stereotaxis (NYSE:STXS) announced today that it submitted its MAGiC catheter for CE mark approval in Europe. The St. Louis-based company designed MAGiC as a robotically navigated, magnetic interventional ablation catheter for minimally invasive cardiac ablation procedures. Used in conjunction with Stereotaxis' robotic systems, the catheter … [Read more...] about Stereotaxis submits robotically navigated ablation catheter for CE mark
Stereotaxis
Stereotaxis opens new headquarters in St. Louis
Surgical robotics company Stereotaxis (NYSE: STXS) is holding a grand opening today for its 45,000 ft² headquarters facility in downtown St. Louis. The new headquarters is located in the renovated historic Globe Building in St. Louis’s growing Downtown North Urban Insight District. It's an all-in-one facility housing research and development, … [Read more...] about Stereotaxis opens new headquarters in St. Louis
Study: Stereotaxis robotic technology reduces silent cerebral embolism during AFib ablation
Stereotaxis announced the positive results from a study of its robotic magnetic navigation system in atrial fibrillation ablation. The multi-center, prospective study evaluated 166 patients with paroxysmal or persistent AFib who underwent pulmonary vein isolation using Stereotaxis' robotic magnetic navigation (RMN) technology or manual contact … [Read more...] about Study: Stereotaxis robotic technology reduces silent cerebral embolism during AFib ablation
Stereotaxis touts positive results in robotic cardiac ablation study
Stereotaxis this week announced positive outcomes of an independent study assessing its robotic cardiac ablation system in pediatric patients. The St. Louis-based company's robotic technology demonstrated superior safety and efficacy in treating atrioventricular reentry tachycardia (AVRT) and atrioventricular nodal reentry tachycardia (AVNRT) in … [Read more...] about Stereotaxis touts positive results in robotic cardiac ablation study
Stereotaxis forms partnership to advance electrophysiology robotics in China
Stereotaxis this week announced it has forged a broad collaboration with Shanghai Microport EP Medtech to advance technology innovation and commercial adoption of electrophysiology robotics in China. The agreement combines MicroPort EP's commercial and product expertise in China's electrophysiology market and Sterotaxis's Robotic Magnetic … [Read more...] about Stereotaxis forms partnership to advance electrophysiology robotics in China
